Condition: Carcinoid Neuroendocrine Cancer
Intervention:
Sponsor: Rutgers University
Recruiting - verified May 2008
By Cancer
3971 items (3971 unread) in 83 feeds
Click on blue folders to expand
Adrenal Gland Cancer
(438)
Ampulla Of Vater
(26)
Anal Cancer
(272)
Angiosarcoma
(69)
Appendix Cancer
(34)
Bile Duct Cancer
(525)
Brain & CNS
(753)
Carcinoid
(165)
Endocrine/Neuroendocrine
(256)
Gall Bladder Cancer
(88)
General
(109)
Hemangioendothelioma
(28)
HemeOnc
(443)
Hepatoblastoma
(61)
Pancreas
(48)
Phyllodes
(12)
Rhabdomyosarcoma
(214)
Sarcoma
(287)
Trials - Carcinoid (9 unread)
-
A Pilot Study to Investigate MEN1 and SDHD Gene Mutation in Carcinoid
Posted: May 2nd, 2008, 10:00am EDT
-
An Investigation of Small Intestinal Carcinoid Carcinoma in Families
Posted: April 17th, 2008, 10:00am EDT
Condition: Carcinoid Carcinoma
Intervention:
Sponsor: Rutgers University
Recruiting - verified April 2008 -
CBT-1 and Paclitaxel in Treating Patients With Refractory, Recurrent, or Advanced Metastatic Solid Tumors
Posted: April 12th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: MDR modulator CBT-1; Drug: paclitaxel; Drug: technetium 99m sestamibi; Procedure: chemosensitization/potentiation therapy; Procedure: drug resistance inhibition treatment; Procedure: parenteral chemotherapy; Procedure: radionuclide imaging
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2008 -
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Posted: April 9th, 2008, 10:00am EDT
Conditions: Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Kidney Cancer; Lung Cancer; Melanoma (Skin); Neuroendocrine Carcinoma of the Skin; Pheochromocytoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: everolimus; Drug: vatalanib; Procedure: antiangiogenesis therapy; Procedure: enzyme inhibitor therapy; Procedure: protein tyrosine kinase inhibitor therapy
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified April 2008 -
Clinical and Pathologic Studies in Neuroendocrine Tumors
Posted: April 9th, 2008, 10:00am EDT
Condition: Carcinoid Tumor
Interventions: Procedure: blood sample draw; Procedure: urine sample
Sponsor: Stanford University
Not yet recruiting - verified May 2008 -
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Posted: April 4th, 2008, 10:00am EDT
Conditions: Anal Cancer; Carcinoma of the Appendix; Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Carcinoid Tumor; Gastrointestinal Stromal Tumor; Liver Cancer; Pancreatic Cancer; Small Intestine Cancer
Interventions: Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Procedure: parenteral chemotherapy; Procedure: pharmacogenomic studies; Procedure: pharmacological study
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Not yet recruiting - verified April 2008 -
Natural History of Familial Carcinoid Tumor
Posted: March 26th, 2008, 10:00am EDT
Conditions: Carcinoid; Familial; PET; Gastrointestinal; Serotonin
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2008 -
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Posted: March 14th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: indinavir sulfate; Drug: ritonavir; Procedure: antiangiogenesis therapy; Procedure: drug modulation therapy; Procedure: enzyme inhibitor therapy; Procedure: radiation therapy; Procedure: radiosensitization
Sponsor: Oncology Institute of Southern Switzerland - Lugano
Recruiting - verified March 2008 -
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors
Posted: February 26th, 2008, 10:00am EST
Conditions: Cervical Cancer; Gastrointestinal Carcinoid Tumor; Lung Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: BB-10901; Procedure: antibody-drug conjugate therapy; Procedure: monoclonal antibody therapy
Sponsor: ImmunoGen, Inc.
Suspended - verified October 2007